Search Results - Anett Helwig

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Dose-reduced Conditioning and Allogeneic Hematopoietic Stem Cell Transplantation from Unrelated Donors in 42 Patients

    Dose-reduced Conditioning and Allogeneic Hematopoietic Stem Cell Transplantation from Unrelated Donors in 42 Patients by Martin Bornhäuser, Christian Thiede, Uwe Platzbecker, Andreas Jenke, Anett Helwig, Runa Plettig, Jens Freiberg-Richter, Christoph Röllig, Gabriele Geissler, Karin Lutterbeck, Uta Oelschlagel, Gerhard Ehninger

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Pharmacokinetics of intravenous mycophenolate mofetil after allogeneic blood stem cell transplantation

    Pharmacokinetics of intravenous mycophenolate mofetil after allogeneic blood stem cell transplantation by Jenke, Andreas, Renner, Ulf, Richte, Maria, Freiberg-Richter, Jens, Platzbecker, Uwe, Helwig, Anett, Thiede, Hans-M, Schäfer-Eckart, Karin, Ehninger, Gerhard, Bornhäuser, Martin

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Graft Versus Host Disease Prophylaxis with Everolimus and Tacrolimus in Patients with Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukaemia (AML) Receiving Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT)

    Graft Versus Host Disease Prophylaxis with Everolimus and Tacrolimus in Patients with Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukaemia (AML) Receiving Allogeneic Periphe... by Platzbecker, Uwe, Pabst, Caroline, Kiani, Alexander, Schetelig, Johannes, Wermke, Martin, Helwig, Anett, Ehninger, Gerhard, Bornhäuser, Martin

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Successful combination of anti‐cd33 antibody (gemtuzumab ozogamicin) and minimal conditioning before second allografting in recurrent acute myeloid leukaemia

    Successful combination of anti‐cd33 antibody (gemtuzumab ozogamicin) and minimal conditioning before second allografting in recurrent acute myeloid leukaemia by Hänel, Mathias, Thiede, Christian, Helwig, Anett, Prange‐Krex, Gabriele, Babatz, Jana, Haack, Michael, Kroschinsky, Frank, Fetscher, Sebastian, Ehninger, Gerhard, Bornhäuser, Martin

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Treatment of relapsing leukemia after allogeneic blood stem cell transplantation by using dose-reduced conditioning followed by donor blood stem cells and GM-CSF

    Treatment of relapsing leukemia after allogeneic blood stem cell transplantation by using dose-reduced conditioning followed by donor blood stem cells and GM-CSF by PLATZBECKER, Uwe, THIEDE, Christian, FREIBERG-RICHTER, Jens, HELWIG, Anett, MOHR, Brigitte, PRANGE, Gabriele, FÜSSEL, Monika, KÖHLER, Thomas, EHNINGER, Gerhard, BORNHÄUSER, Martin

    Published in Annals of hematology
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Successful combination of anti-CD33 antibody (gemtuzumab ozogamicin) and minimal conditioning before second allografting in recurrent acute myeloid leukaemia

    Successful combination of anti-CD33 antibody (gemtuzumab ozogamicin) and minimal conditioning before second allografting in recurrent acute myeloid leukaemia by Hänel, Mathias, Thiede, Christian, Helwig, Anett, Prange-Krex, Gabriele, Babatz, Jana, Haack, Michael, Kroschinsky, Frank, Fetscher, Sebastian, Ehninger, Gerhard, Bornhäuser, Martin

    Get full text
    Report
    Save to List
    Saved in:

Search Tools: